ascorbic acid powder
a a h pharmaceuticals ltd - ascorbic acid - not applicable - 1mg/1mg
ascorbic acid powder
j m loveridge ltd - ascorbic acid - not applicable - 1mg/1mg
ascorbic acid powder
thornton & ross ltd - ascorbic acid - not applicable - 1mg/1mg
ascorbic acid powder
alliance healthcare (distribution) ltd - ascorbic acid - not applicable - 1mg/1mg
paracetamol 1000mg, phenylephrine hydrochloride 12.2mg, powder for oral solution, lemon flavourparacetamol 1000mg, phenylephrine hcl 12.2mgpowder for oral solution
wick pharma - zweigniederlassung der procter & gamble gmbh - phenylephrine hydrochloride; paracetamol - powder for oral solution - 1000/12.2 milligram(s) - anilides; paracetamol, combinations excl. psycholeptics
flublok quadrivalent vaccine (recombinant) solution for injection 0.5ml pre-filled syringes
recombinant) solution for injection 0.5ml pre-filled syringes (imported (united states) - recombinant haemagglutinin proteins - solution for injection
prochlorperazine maleate tablet
redpharm drug, inc. - prochlorperazine maleate (unii: i1t8o1jtl6) (prochlorperazine - unii:yhp6ylt61t) - prochlorperazine 10 mg - for control of severe nausea and vomiting. for the treatment of schizophrenia. prochlorperazine is effective for the short-term treatment of generalized non-psychotic anxiety. however, prochlorperazine is not the first drug to be used in therapy for most patients with non-psychotic anxiety, because certain risks associated with its use are not shared by common alternative treatments (e.g., benzodiazepines). when used in the treatment of non-psychotic anxiety, prochlorperazine should not be administered at doses of more than 20 mg per day or for longer than 12 weeks, because the use of prochlorperazine at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible (see warnings). the effectiveness of prochlorperazine as treatment for non-psychotic anxiety was established in 4 week clinical studies of outpatients with generalized anxiety disorder. this evidence does not predict that prochlorperazine will be useful in patients with other non-psychotic conditions in wh
prochlorperazine maleate tablet, film coated
redpharm drug, inc. - prochlorperazine maleate (unii: i1t8o1jtl6) (prochlorperazine - unii:yhp6ylt61t) - prochlorperazine 5 mg - for control of severe nausea and vomiting. for the treatment of schizophrenia. prochlorperazine is effective for the short-term treatment of generalized non-psychotic anxiety. however, prochlorperazine is not the first drug to be used in therapy for most patients with non-psychotic anxiety, because certain risks associated with its use are not shared by common alternative treatments (e.g., benzodiazepines). when used in the treatment of non-psychotic anxiety, prochlorperazine should not be administered at doses of more than 20 mg per day or for longer than 12 weeks, because the use of prochlorperazine at higher doses or for longer intervals may cause persistent tardive dyskinesia that may prove irreversible (see warnings). the effectiveness of prochlorperazine as treatment for non-psychotic anxiety was established in 4 week clinical studies of outpatients with generalized anxiety disorder. this evidence does not predict that prochlorperazine will be useful in patients with other non-psychotic conditions in wh
sinus and allergy maximum strength- chlorpheniramine maleate, phenylephrine hcl tablet
chain drug consortium - chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - chlorpheniramine maleate 4 mg - antihistamine nasal decongestant - temporarily relieves these symptoms due to hay fever (allergic rhinitis) or other upper respiratory allergies: runny nose sneezing itching of the nose or throat itchy, watery eyes sinus congestion and pressure nasal congestion - runny nose - sneezing - itching of the nose or throat - itchy, watery eyes - sinus congestion and pressure - nasal congestion
coldrex pe phenylephrine cold & flu plus
haleon new zealand ulc - caffeine 25mg; ; paracetamol 500mg; ; ; ; phenylephrine hydrochloride 5mg; ; - film coated tablet - active: caffeine 25mg paracetamol 500mg phenylephrine hydrochloride 5mg excipient: hypromellose mastercote fa1202 macrogol 400 maize starch microcrystalline cellulose potassium sorbate povidone purified talc sodium laurilsulfate starch stearic acid sunset yellow fcf